This article is a correction to:
Atorvastatin May Attenuate Recurrence of Chronic Subdural Hematoma
Frontiers Editorial OfficeA retraction of the Original Research Article
Atorvastatin May Attenuate Recurrence of Chronic Subdural Hematoma
by Liu, H., Luo, Z., Liu, Z., Yang, J., and Kan, S. (2016). Front. Neurosci. 10:303. doi: 10.3389/fnins.2016.00303
The Journal and Authors retract the 28 June 2016 article cited above for the following reasons provided by the Authors:
In one of our collaborating centers (The People's Hospital of AnQiu City), 38 patients were enrolled in an atorvastatin group. Among them, 26 patients lost to follow-up were categorized and analyzed as “non-recurrence group.” It was a fundamental error and thus we must retract this article. We apologize for any inconvenience caused by the retraction of this article.
Citation: Frontiers Editorial Office (2016) Retraction: Atorvastatin May Attenuate Recurrence of Chronic Subdural Hematoma. Front. Neurosci. 10:465. doi: 10.3389/fnins.2016.00465
Received: 27 September 2016; Accepted: 27 September 2016;
Published: 07 October 2016.
Approved by:
Arjan Blokland, Maastricht University, NetherlandsCopyright © 2016 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, editorial.office@frontiersin.org